COP regimen: Difference between revisions
No edit summary |
No edit summary |
||
| (One intermediate revision by the same user not shown) | |||
| Line 3: | Line 3: | ||
{{CMG}}; {{AE}} {{AV}} | {{CMG}}; {{AE}} {{AV}} | ||
{{SK}} | {{SK}} CVP; CVP regimen; Cyclophosphamide/Vincristine/Prednisone | ||
==Overview== | ==Overview== | ||
{{PAGENAME}} refers to a regimen consisting of [[cyclophosphamide]], [[vincristine]], and [[prednisone]] used to treat [[ | {{PAGENAME}} refers to a regimen consisting of [[cyclophosphamide]], [[vincristine]], and [[prednisone]] used to treat [[Non Hodgkin's lymphoma]]. | ||
==Regimen== | ==Regimen== | ||
{{chemo|C|Cyclophosphamide}} | {{chemo|C|Cyclophosphamide}} | ||
{{chemo| | {{chemo|O|Vincristine (Oncovin)}} | ||
{{chemo|P|Prednisone}} | {{chemo|P|Prednisone}} | ||
==Indications== | ==Indications== | ||
* [[ | * [[Non Hodgkin's lymphoma]]<ref name="pmid4935774">{{cite journal| author=Luce JK, Gamble JF, Wilson HE, Monto RW, Isaacs BL, Palmer RL et al.| title=Combined cyclophosphamide vincristine, and prednisone therapy of malignant lymphoma. | journal=Cancer | year= 1971 | volume= 28 | issue= 2 | pages= 306-17 | pmid=4935774 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=4935774 }} </ref> | ||
==References== | ==References== | ||
Latest revision as of 13:11, 12 March 2015
|
WikiDoc Resources for COP regimen |
|
Articles |
|---|
|
Most recent articles on COP regimen Most cited articles on COP regimen |
|
Media |
|
Powerpoint slides on COP regimen |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on COP regimen at Clinical Trials.gov Clinical Trials on COP regimen at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on COP regimen
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on COP regimen Discussion groups on COP regimen Patient Handouts on COP regimen Directions to Hospitals Treating COP regimen Risk calculators and risk factors for COP regimen
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for COP regimen |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]
Synonyms and keywords: CVP; CVP regimen; Cyclophosphamide/Vincristine/Prednisone
Overview
COP regimen refers to a regimen consisting of cyclophosphamide, vincristine, and prednisone used to treat Non Hodgkin's lymphoma.
Regimen
CCyclophosphamide
OVincristine (Oncovin)
PPrednisone
Indications
References
- ↑ Luce JK, Gamble JF, Wilson HE, Monto RW, Isaacs BL, Palmer RL; et al. (1971). "Combined cyclophosphamide vincristine, and prednisone therapy of malignant lymphoma". Cancer. 28 (2): 306–17. PMID 4935774.